Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nasaleze International is a specialized healthcare company headquartered in the Isle of Man that focuses on the development and global distribution of natural nasal powder sprays. The company's proprietary technology utilizes a unique cellulose powder that, upon contact with the moisture in the nose, creates a fast-acting muco-adhesive gel barrier. This physical shield effectively traps and neutralizes airborne allergens and viruses before they can trigger symptoms or infection. Nasaleze products, including their flagship Allergy and Cold & Flu Blocker lines, offer a non-drowsy, drug-free alternative to traditional pharmaceuticals. The company's portfolio is clinically backed and available in over 50 international markets for both adults and children.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nasaleze International.